US 8841302
HCV inhibitor and therapeutic agent combinations
granted A61KA61K31/00A61K31/404
Quick answer
US patent 8841302 (HCV inhibitor and therapeutic agent combinations) held by PTC THERAPEUTICS, INC. expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/00, A61K31/404, A61K45/06, A61P